NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.
Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Large T1 contrast enhancement using superparamagnetic nanoparticles in ultra-low field MRI
Published
Author(s)
Xiaolu Yin, Stephen E. Russek, Gary Zabow, Fan Sun, Jeotikanta Mohapatra, Kathryn E. Keenan, Michael A. Boss, Hao Zeng, Sy-Hwang Liou, John M. Moreland
Abstract
Superparamagnetic iron oxide nanoparticles (SPIONs) are widely investigated and utilized as magnetic resonance imaging (MRI) contrast and therapy agents due to their large magnetic moments. Local field inhomogeneities caused by these high magnetic moments are used to generate T2 contrast in clinical high-field MRI, resulting in signal loss (darker contrast). Here we present strong T1 contrast enhancement (brighter contrast) from SPIONs (diameters from 11 nm to 22 nm) as observed in the ultra-low field (ULF) MRI at 0.13 mT. We have achieved a high longitudinal relaxivity for 18 nm SPION solutions, r1 = 615 s−1 mM−1, which is two orders of magnitude larger than typical commercial Gd-based T1 contrast agents operating at high fields (1.5 T and 3 T). The significantly enhanced r1 value at ultralow fields is attributed to the coupling of proton spins with SPION magnetic fluctuations (Brownian and Néel) associated with a low frequency peak in the imaginary part of AC susceptibility (χ). SPION-based T1-weighted ULF MRI has the advantages of enhanced signal, shorter imaging times, and iron-oxide based nontoxic biocompatible agents. This approach shows promise to become a functional imaging technique, similar to PET, where low spatial resolution is compensated for by important functional information.
Yin, X.
, Russek, S.
, Zabow, G.
, Sun, F.
, Mohapatra, J.
, Keenan, K.
, Boss, M.
, Zeng, H.
, Liou, S.
and Moreland, J.
(2018),
Large T1 contrast enhancement using superparamagnetic nanoparticles in ultra-low field MRI, Nature - Scientific Reports, [online], https://doi.org/10.1038/s41598-018-30264-5
(Accessed October 8, 2025)